Association Between Peritoneal Carcinomatosis Index (PCI) Assessed by CT and Pathological Parameters and Short-Term Prognosis of Rectal Cancer
View abstract on PubMed
Summary
This summary is machine-generated.Preoperative CT-based Peritoneal Carcinomatosis Index (PCI) can predict short-term prognosis in rectal cancer patients undergoing surgery after neoadjuvant therapy. This index helps guide clinical decisions and improve patient outcomes.
Area Of Science
- Oncology
- Radiology
- Surgical Pathology
Background
- Rectal cancer management involves complex staging and prognosis assessment.
- Neoadjuvant therapy is a common treatment modality for rectal cancer.
- Accurate prediction of short-term postoperative outcomes is crucial for patient care.
Purpose Of The Study
- To explore the correlation between the CT-based Peritoneal Carcinomatosis Index (CT-PCI) and pathological parameters in rectal cancer.
- To investigate the association between preoperative CT-PCI and short-term postoperative prognosis.
- To identify CT-PCI as a predictor of postoperative complications.
Main Methods
- Retrospective analysis of 198 rectal cancer patients from January 2017 to December 2022.
- Classification of patients into normal and low CT-PCI groups based on preoperative CT scans.
- Univariate and Multivariable logistic regression, and ROC curve analysis to assess risk factors and predictive value.
Main Results
- Significant differences in baseline characteristics and postoperative complications (Clavien-Dindo ≥ Grade II) were observed between CT-PCI groups.
- CT-PCI was identified as an independent risk factor for postoperative complications (OR=2.254, P < .05).
- The ROC curve showed a high predictive accuracy for CT-PCI in forecasting complications (AUC = 0.854).
Conclusions
- Preoperative CT-PCI is a valuable tool for evaluating the short-term prognosis of rectal cancer patients post-neoadjuvant therapy and surgery.
- CT-PCI can aid in clinical decision-making and prompt interventions.
- Utilizing CT-PCI can enhance short-term patient outcomes in rectal cancer care.

